Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

567 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Guidance on platelet transfusion for patients with hypoproliferative thrombocytopenia.
Nahirniak S, Slichter SJ, Tanael S, Rebulla P, Pavenski K, Vassallo R, Fung M, Duquesnoy R, Saw CL, Stanworth S, Tinmouth A, Hume H, Ponnampalam A, Moltzan C, Berry B, Shehata N; International Collaboration for Transfusion Medicine Guidelines. Nahirniak S, et al. Among authors: stanworth s. Transfus Med Rev. 2015 Jan;29(1):3-13. doi: 10.1016/j.tmrv.2014.11.004. Epub 2014 Nov 27. Transfus Med Rev. 2015. PMID: 25537844
Quality of Evidence-Based Guidelines for Transfusion of Red Blood Cells and Plasma: A Systematic Review.
Pavenski K, Stanworth S, Fung M, Wood EM, Pink J, Murphy MF, Hume H, Nahirniak S, Webert KE, Tanael S, Landry D, Shehata N; International Collaboration for Transfusion Medicine Guidelines (ICTMG). Pavenski K, et al. Among authors: stanworth s. Transfus Med Rev. 2018 Jun 1:S0887-7963(18)30017-8. doi: 10.1016/j.tmrv.2018.05.004. Online ahead of print. Transfus Med Rev. 2018. PMID: 29921477 Review.
A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation.
Estcourt LJ, Crighton GL, Wood EM, Stanworth S, Trivella M, Doree C, Tinmouth A, Murphy MF. Estcourt LJ, et al. Among authors: stanworth s. Cochrane Database Syst Rev. 2014;(3):CD010981. doi: 10.1002/14651858.CD010981. Cochrane Database Syst Rev. 2014. Update in: Cochrane Database Syst Rev. 2015 Sep 30;(9):CD010981. doi: 10.1002/14651858.CD010981.pub2 PMID: 25722649 Free PMC article. Updated.
Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation.
Estcourt LJ, Stanworth S, Doree C, Trivella M, Hopewell S, Murphy MF, Tinmouth A. Estcourt LJ, et al. Among authors: stanworth s. Cochrane Database Syst Rev. 2014;(3):CD010983. doi: 10.1002/14651858.CD010983. Cochrane Database Syst Rev. 2014. Update in: Cochrane Database Syst Rev. 2015 Nov 18;(11):CD010983. doi: 10.1002/14651858.CD010983.pub2 PMID: 25722651 Free PMC article. Updated.
Different doses of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation.
Estcourt LJ, Stanworth S, Doree C, Trivella M, Hopewell S, Murphy MF, Tinmouth A. Estcourt LJ, et al. Among authors: stanworth s. Cochrane Database Syst Rev. 2014;(3):CD010984. doi: 10.1002/14651858.CD010984. Cochrane Database Syst Rev. 2014. Update in: Cochrane Database Syst Rev. 2015 Oct 27;(10):CD010984. doi: 10.1002/14651858.CD010984.pub2 PMID: 25722652 Free PMC article. Updated.
The Age of Blood Evaluation (ABLE) randomized controlled trial: study design.
Lacroix J, Hébert P, Fergusson D, Tinmouth A, Blajchman MA, Callum J, Cook D, Marshall JC, McIntyre L, Turgeon AF; ABLE study group. Lacroix J, et al. Transfus Med Rev. 2011 Jul;25(3):197-205. doi: 10.1016/j.tmrv.2011.03.001. Epub 2011 May 6. Transfus Med Rev. 2011. PMID: 21550205 Clinical Trial.
567 results